Literature DB >> 26846943

Approaches for characterizing threshold dose-response relationships for DNA-damage pathways involved in carcinogenicity in vivo and micronuclei formation in vitro.

Rebecca A Clewell1, Melvin E Andersen2.   

Abstract

Assessing the shape of dose-response curves for DNA-damage in cellular systems and for the consequences of DNA damage in intact animals remains a controversial topic. This overview looks at aspects of the pharmacokinetics (PK) and pharmacodynamics (PD) of cellular DNA-damage/repair and their role in defining the shape of dose-response curves using an in vivo example with formaldehyde and in vitro examples for micronuclei (MN) formation with several test compounds. Formaldehyde is both strongly mutagenic and an endogenous metabolite in cells. With increasing inhaled concentrations, there were transitions in gene changes, from activation of selective stress pathway genes at low concentrations, to activation of pathways for cell-cycle control, p53-DNA damage, and stem cell niche pathways at higher exposures. These gene expression changes were more consistent with dose-dependent transitions in the PD responses to formaldehyde in epithelial cells in the intact rat rather than the low-dose linear extrapolation methods currently used for carcinogens. However, more complete PD explanations of non-linear dose response for creation of fixed damage in cells require detailed examination of cellular responses in vitro using measures of DNA damage and repair that are not easily accessible in the intact animal. In the second section of the article, we illustrate an approach from our laboratory that develops fit-for-purpose, in vitro assays and evaluates the PD of DNA damage and repair through studies using prototypical DNA-damaging agents. Examination of a broad range of responses in these cells showed that transcriptional upregulation of cell cycle control and DNA repair pathways only occurred at doses higher than those causing overt damage fixed damage-measured as MN formation. Lower levels of damage appear to be handled by post-translational repair process using pre-existing proteins. In depth evaluation of the PD properties of one such post-translational process (formation of DNA repair centers; DRCs) has indicated that the formation of DRCs and their ability to complete repair before replication are consistent with threshold behaviours for mutagenesis and, by extension, with chemical carcinogenesis.
© The Author 2016. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26846943     DOI: 10.1093/mutage/gev078

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  4 in total

1.  Development and validation of a high-throughput transcriptomic biomarker to address 21st century genetic toxicology needs.

Authors:  Heng-Hong Li; Renxiang Chen; Daniel R Hyduke; Andrew Williams; Roland Frötschl; Heidrun Ellinger-Ziegelbauer; Raegan O'Lone; Carole L Yauk; Jiri Aubrecht; Albert J Fornace
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

Review 2.  What is the meaning of 'A compound is carcinogenic'?

Authors:  Dieter Schrenk
Journal:  Toxicol Rep       Date:  2018-04-07

3.  An Automated, Single Cell Quantitative Imaging Microscopy Approach to Assess Micronucleus Formation, Genotoxicity and Chromosome Instability.

Authors:  Chloe C Lepage; Laura L Thompson; Bradley Larson; Kirk J McManus
Journal:  Cells       Date:  2020-02-02       Impact factor: 6.600

4.  The codification of hazard and its impact on the hazard versus risk controversy.

Authors:  John E Doe; Alan R Boobis; Samuel M Cohen; Vicki L Dellarco; Penelope A Fenner-Crisp; Angelo Moretto; Timothy P Pastoor; Rita S Schoeny; Jennifer G Seed; Douglas C Wolf
Journal:  Arch Toxicol       Date:  2021-09-24       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.